Factors relating to the short term effectiveness of percutaneous biliary drainage for hilar cholangiocarcinoma

World Journal of Gastroenterology

Volumn 15, Issue 41, 2009, Pages 5206-5210

  Tsai, Hong Ming ^a   Chuang, Chiao Hsiung ^a   Lin, Xi Zhang ^a   Chen, Chiung Yu ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cholangiocarcinoma; Percutaneous biliary drainage; Treatment effectiveness

Indexed keywords

BILIRUBIN;

AGED; ARTICLE; BILE DUCT CARCINOMA; BILE SECRETION; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; DEMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LABORATORY TEST; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; POSTOPERATIVE PERIOD; PROTHROMBIN TIME; RETROSPECTIVE STUDY; SURGICAL APPROACH; SURVIVAL TIME;

EID: 73449109841     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.5206     Document Type: Article

References (18)

1. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224: 463-473; discussion 473-475
2. Blechacz BR, Gores GJ. Cholangiocarcinoma. Clin Liver Dis 2008; 12: 131-150, ix
3. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, Youssef BA M, Klimstra D, Blumgart LH. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507-517; discussion 517-519
4. Singhal D, van Gulik TM, Gouma DJ. Palliative management of hilar cholangiocarcinoma. Surg Oncol 2005; 14: 59-74
5. Weber A, Landrock S, Schneider J, Stangl M, Neu B, Born P, Classen M, Rösch T, Schmid RM, Prinz C. Long-term outcome and prognostic factors of patients with hilar cholangiocarcinoma. World J Gastroenterol 2007; 13: 1422-1426
6. Rerknimitr R, Kladcharoen N, Mahachai V, Kullavanijaya P. Result of endoscopic biliary drainage in hilar cholangiocarcinoma. J Clin Gastroenterol 2004; 38: 518-523
7. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215: 31-38
8. Chen CY, Shiesh SC, Lin XZ. Indicators of liver excretory function in patients undergoing biliary decompression for obstructive jaundice. Hepatogastroenterology 1998; 45: 786-790
9. Alpini G, Lenzi R, Sarkozi L, Tavoloni N. Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules. J Clin Invest 1988; 81: 569-578
10. Malhi H, Gores GJ. Cellular and molecular mechanisms of liver injury. Gastroenterology 2008; 134: 1641-1654
11. Miyoshi H, Rust C, Roberts PJ, Burgart LJ, Gores GJ. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 1999; 117: 669-677
12. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, Gores GJ. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103: 137-145
13. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, Gores GJ. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 2000; 278: G992-G999
14. Weston BR, Ross WA, Wolff RA, Evans D, Lee JE, Wang X, Xiao LC, Lee JH. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopa ncreatography? Cancer 2008; 112: 2417-2423
15. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008; 48: 308-321
16. Stoker J, Laméris JS, van Blankenstein M. Percutaneous metallic self-expandable endoprostheses in malignant hilar biliary obstruction. Gastrointest Endosc 1993; 39: 43-49
17. Shim CS, Cheon YK, Cha SW, Bhandari S, Moon JH, Cho YD, Kim YS, Lee LS, Lee MS, Kim BS. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 2005; 37: 425-433
18. Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005; 100: 2426-2430